A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and treatment of tongue squamous cell carcinoma (TSCC). By harnessing gold nanoparticles coupled with the HN-1 peptide, this innovative system targets TSCC cells with unprecedented precision, offering enhanced photothermal therapy (PTT) and dual-mode imaging capabilities. With the ability to localize photosensitizers at tumor sites, the system boosts the effectiveness of tumor ablation, while its fluorescence and computed tomography (CT) imaging functions ensure accurate tumor detection and surgical margin identification. This breakthrough technology holds the potential to significantly improve treatment outcomes and the quality of life for patients battling TSCC.
Tongue squamous cell carcinoma (TSCC) is an aggressive cancer that is notoriously difficult to treat, with a high rate of metastasis and recurrence. Conventional therapies such as surgery, chemotherapy, and radiotherapy often lack the necessary specificity, resulting in debilitating side effects and diminished quality of life. Furthermore, accurately defining tumor margins during surgery remains a challenge, which can lead to incomplete resections and higher recurrence rates. With a grim prognosis and high mortality, TSCC underscores the urgent need for more effective, targeted therapies that can improve survival rates while minimizing collateral damage to healthy tissues.
Published (DOI: 10.1038/s41368-024-00343-7) on January 14, 2025, in the International Journal of Oral Science, researchers from Jilin University introduced the Au-HN-1 nanosystem, an innovative development designed for the dual purpose of targeting and treating TSCC. The study demonstrates how gold nanoparticles, modified with the HN-1 peptide, enable precise targeting of cancer cells, offering hope for more effective treatments for this deadly disease.
The Au-HN-1 nanosystem represents a quantum leap in the treatment and diagnosis of TSCC. By linking gold nanodots with the HN-1 peptide, the research team achieved highly selective targeting of TSCC cells, significantly improving the accumulation of photosensitizers at tumor sites. This targeted approach enhanced the efficacy of photothermal therapy (PTT) in mouse models, reducing tumor volumes without causing systemic toxicity. The nanosystem’s dual-mode imaging (fluorescence and CT) also allowed for accurate tumor localization and delineation of surgical margins—an essential factor in improving surgical outcomes. With its stability, biocompatibility, and minimal side effects, the Au-HN-1 system shows promising potential for long-term in vivo imaging and personalized cancer therapy. By combining diagnostic and therapeutic functions into a single, versatile system, this breakthrough minimizes damage to healthy tissues, marking a significant advance in cancer nanotechnology.
Dr. Guoqing Wang, the lead researcher of the study, emphasized the importance of this breakthrough: “The Au-HN-1 nanosystem is a major step forward in TSCC treatment, as it integrates targeted therapy with dual-mode imaging. This combination enhances therapeutic precision while safeguarding healthy tissue, pushing the boundaries of what’s possible in cancer nanotherapy.”
The Au-HN-1 nanosystem could transform the landscape of TSCC treatment and beyond. Its ability to improve photothermal therapy through targeted delivery of photosensitizers, coupled with real-time imaging, allows for precise tumor ablation and clearer tumor margin identification. This technology has the potential to revolutionize surgical procedures, reducing recurrence rates and improving patient outcomes. Furthermore, the versatility of the nanosystem suggests that it may be applicable to other head and neck cancers, offering hope for more effective and minimally invasive treatments. As ongoing research refines this system, it may pave the way for more personalized and precise cancer therapies, ultimately enhancing the lives of patients with TSCC and related malignancies.
Hao, M., et al. (2025). Tongue squamous cell carcinoma-targeting Au-HN-1 nanosystem for CT imaging and photothermal therapy. International Journal of Oral Science. doi.org/10.1038/s41368-024-00343-7.

News
Specially engineered antibody delivers RNA therapy to treatment-resistant tumors
Elias Quijano, PhD; Diana Martinez-Saucedo, PhD; Zaira Ianniello, PhD; and Natasha Pinto-Medici, PhD, there are 25 other contributors, most from Yale's Department of Therapeutic Radiology and from the departments of genetics, molecular biophysics and [...]
Vaccinated women face fewer cervical cancer risks
New data from Denmark shows the HPV vaccine’s powerful long-term impact, while also revealing why cervical cancer screening is still essential. A Danish study published in the journal Eurosurveillance reports that women who received the human [...]
3D-printed implant offers a potential new route to repair spinal cord injuries
A research team at RCSI University of Medicine and Health Sciences has developed a 3-D printed implant to deliver electrical stimulation to injured areas of the spinal cord, offering a potential new route to [...]
Nanocrystals Carrying Radioisotopes Offer New Hope for Cancer Treatment
The Science Scientists have developed tiny nanocrystal particles made up of isotopes of the elements lanthanum, vanadium, and oxygen for use in treating cancer. These crystals are smaller than many microbes and can carry isotopes of [...]
New Once-a-Week Shot Promises Life-Changing Relief for Parkinson’s Patients
A once-a-week shot from Australian scientists could spare people with Parkinson’s the grind of taking pills several times a day. The tiny, biodegradable gel sits under the skin and releases steady doses of two [...]
Weekly injectable drug offers hope for Parkinson’s patients
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the University of South Australia [...]
Most Plastic in the Ocean Is Invisible—And Deadly
Nanoplastics—particles smaller than a human hair—can pass through cell walls and enter the food web. New research suggest 27 million metric tons of nanoplastics are spread across just the top layer of the North [...]
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]